NCT01627561 2020-04-10Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years OldGlaxoSmithKlinePhase 3 Completed148 enrolled 28 charts